1. Home
  2. CPSS vs KZIA Comparison

CPSS vs KZIA Comparison

Compare CPSS & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$9.56

Market Cap

201.1M

Sector

Finance

ML Signal

N/A

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$9.57

Market Cap

186.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
KZIA
Founded
1991
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.1M
186.7M
IPO Year
2010
2002

Fundamental Metrics

Financial Performance
Metric
CPSS
KZIA
Price
$9.56
$9.57
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $19.50
AVG Volume (30 Days)
21.8K
★ 378.8K
Earning Date
05-11-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1.27
N/A
EPS
★ 0.50
N/A
Revenue
★ $434,470,000.00
N/A
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.74
★ N/A
Revenue Growth
★ 10.41
N/A
52 Week Low
$7.34
$4.86
52 Week High
$10.49
$17.40

Technical Indicators

Market Signals
Indicator
CPSS
KZIA
Relative Strength Index (RSI) 53.09 35.92
Support Level $8.97 $5.15
Resistance Level $9.66 $14.85
Average True Range (ATR) 0.33 0.79
MACD 0.01 -0.14
Stochastic Oscillator 75.00 16.18

Price Performance

Historical Comparison
CPSS
KZIA

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: